Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCDC22 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PIWIL2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | PSMB6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | GANC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | TIMM10 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | LGALS3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | CTB-133G6.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | PCDHB12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | SLC4A1AP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ATAD3C | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |